Preston Klassen Metacrine, Inc. (MTCR) insider trading activity

MTCR Quotes by TradingView

Preston Klassen is Director of Metacrine, Inc.. Currently has a direct ownership of 1.38 Million shares of MTCR, which is worth approximately $0. The most recent transaction as insider was on Mar 23, 2023, when has been sold 842,211 shares (Common Stock) at a price of $0.47 per share, resulting in proceeds of $395,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.38M
0% 3M change
0% 12M change
Total Value Held $0

Preston Klassen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2023
SELL
Grant, award, or other acquisition
$395,839 $0.47 p/Share
842,211 Reduced 37.83%
1,384,116 Common Stock
Jan 26 2023
SELL
Open market or private sale
$156,048 $0.41 p/Share
380,605 Reduced 41.26%
541,905 Common Stock
Apr 19 2022
SELL
Open market or private sale
$22,821 $0.51 p/Share
44,748 Reduced 4.63%
922,510 Common Stock
Apr 14 2022
BUY
Grant, award, or other acquisition
-
104,500 Added 9.75%
967,258 Common Stock
Feb 27 2022
BUY
Grant, award, or other acquisition
-
842,211 Added 49.4%
862,758 Common Stock
May 20 2021
BUY
Open market or private purchase
$74,791 $3.64 p/Share
20,547 Added 50.0%
20,547 Common Stock

Also insider at

RGLS
Regulus Therapeutics Inc. Healthcare
President & Head of R & D
PK

Preston Klassen

Director
San Diego, CA

Track Institutional and Insider Activities on MTCR

Follow Metacrine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTCR shares.

Notify only if

Insider Trading

Get notified when an Metacrine, Inc. insider buys or sells MTCR shares.

Notify only if

News

Receive news related to Metacrine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTCR